Effect of weight reduction on leptin, total ghrelin and obestatin concentrations in prepubertal children

T Arrigo1, E Gitto, V Ferraù

  • 1Department of Pediatrics, Genetics and Immunology Unit, University of Messina, Italy.

Insights

Weight loss in obese children significantly alters key hormones like leptin, ghrelin, and obestatin. These changes suggest hormones are linked to childhood obesity and metabolism, not its cause.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Research
  • Obesity Studies

Background:

  • Childhood obesity is a growing concern with complex metabolic implications.
  • Hormonal regulation of appetite and metabolism, including leptin, ghrelin, and obestatin, is crucial in pediatric populations.
  • Understanding these hormonal changes in response to weight loss is vital for effective interventions.

Purpose of the Study:

  • To investigate fasting levels of glucose, insulin, leptin, total ghrelin, and obestatin in prepubescent obese children.
  • To evaluate the impact of a 6-month lifestyle intervention (nutrition and physical activity) on these hormone levels.
  • To compare hormonal profiles between obese children and normal-weight controls.

Main Methods:

  • Study included 35 prepubescent obese children and 20 normal-weight controls.
  • Fasting plasma concentrations of glucose, insulin, HOMA-IR, leptin, total ghrelin, and obestatin were measured.
  • Measurements were taken at baseline and after a 6-month lifestyle intervention program.

Main Results:

  • Obese children initially exhibited higher leptin and obestatin, and lower ghrelin levels compared to controls.
  • Weight loss intervention significantly reduced plasma leptin and insulin levels.
  • Ghrelin and obestatin concentrations significantly increased following the weight loss intervention.

Conclusions:

  • Weight loss in prepubescent children significantly modifies leptin, ghrelin, and obestatin levels.
  • Hormone levels are closely associated with childhood obesity, playing a role in metabolism.
  • These hormones appear to be a consequence, rather than a cause, of obesity-related metabolic changes.

Related Concept Videos

Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...